20/20 Biolabs, Inc. Common Stock (AIDX) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

20/20 Biolabs, Inc. Common Stock (AIDX) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $4.9M, listed on NASDAQ, employing roughly 13 people, carrying a beta of -0.42 to the broader market. 20/20 GeneSystems, Inc. Led by Jonathan Cohen, public since 2023-06-15.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for AIDX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →